Adicet Bio Inc Asset Resilience Ratio

Latest as of June 2026: 57.41%

Adicet Bio Inc asset resilience ratio. Adicet Bio Inc (ACET) has an Asset Resilience Ratio of 57.41% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ACET defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$85.06 Million

Cash + Short-term Investments

Total Assets

$148.17 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Adicet Bio Inc (2008–2025)

Asset resilience ratio of Adicet Bio Inc from 2008 to 2025. This chart shows how Adicet Bio Inc's Asset Resilience Ratio has changed over time. Read ACET liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Adicet Bio Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Adicet Bio Inc's balance sheet.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$85.06 Million	57.41%
Total Liquid Assets	$85.06 Million	57.41%

Asset Resilience Insights

Very High Liquidity: Adicet Bio Inc maintains exceptional liquid asset reserves at 57.41% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Adicet Bio Inc Industry Peers by Asset Resilience Ratio

Compare Adicet Bio Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Bavarian Nordic CO:BAVA	Biotechnology	10.83%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Adicet Bio Inc Asset Resilience Ratio by Year (2008–2025)

Adicet Bio Inc asset resilience ratio by year from 2008 to 2025. The table below shows the annual Asset Resilience Ratio data for Adicet Bio Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	62.18%	$119.61 Million	$192.35 Million	+7.78pp
2024-12-31	54.40%	$119.81 Million	$220.22 Million	--
2023-12-31	0.00%	$0.00	$207.29 Million	--
2021-12-31	0.00%	$0.00	$338.94 Million	--
2020-12-31	6.69%	$10.28 Million	$153.84 Million	-56.80pp
2019-12-31	63.48%	$51.79 Million	$81.59 Million	-28.37pp
2018-12-31	91.86%	$100.99 Million	$109.94 Million	+88.15pp
2017-12-31	3.71%	$2.05 Million	$55.19 Million	+3.54pp
2016-12-31	0.16%	$881.00K	$540.78 Million	-0.53pp
2015-12-31	0.70%	$3.42 Million	$489.77 Million	+0.54pp
2014-12-31	0.16%	$746.00K	$467.98 Million	-0.50pp
2013-12-31	0.66%	$2.14 Million	$323.43 Million	+0.16pp
2012-12-31	0.51%	$1.52 Million	$299.28 Million	+0.19pp
2011-12-31	0.32%	$943.00K	$294.99 Million	+0.16pp
2010-12-31	0.15%	$335.00K	$216.56 Million	-0.13pp
2009-12-31	0.29%	$541.00K	$189.27 Million	+0.02pp
2008-12-31	0.27%	$548.00K	$205.50 Million	--

pp = percentage points

About Adicet Bio Inc

NASDAQ:ACET USA Biotechnology

Market Cap

$29.02 Million

Market Cap Rank

#23703 Global

#5154 in USA

Share Price

$3.10

Change (1 day)

-2.21%

52-Week Range

$0.47 - $9.73

All Time High

$145.95